CHM.CN Waverunner Capital Inc. (CNQ) up 900% 16 Feb 2026: liquidity risk check

CHM.CN stock grabbed market attention in market hours on 16 Feb 2026 after the share price moved to C$0.05 from a prior close of C$0.005, a 900.00% headline change that signals heavy intraday interest. The move contrasts with a 50-day average of C$0.042 and a 200-day average of C$0.048, and comes against an average volume of 28,908.00 shares. We flag this as a high-volume mover trade cue and use Meyka AI data and sector context to separate short-term momentum from underlying fundamentals.

Price action and high-volume mover signal for CHM.CN stock

CHM.CN stock jumped to C$0.05 during market hours on 16 Feb 2026, up C$0.045 from the previous C$0.005 close, a 900.00% increase. This price spike, recorded alongside an average volume of 28,908.00, is consistent with a low-float, speculative surge rather than a steady, liquidity-driven rally.

Traders should note the one-day range held at C$0.05 (day low and day high same reported), which often indicates tightly clustered trades or delayed reporting. On a high-volume movers strategy, this is a signal to confirm execution liquidity on CNQ before entering new positions.

Fundamentals and valuation: what CHM.CN stock shows

Waverunner Capital Inc. (CHM.CN) reports a market cap of C$37,211,650.00 with 744,233,000.00 shares outstanding. The company shows trailing EPS at -0.01 and a negative PE metric, listed as -5.00, reflecting losses and limited operating scale.

Key balance metrics point to stress: book value per share is -0.1092776357 and cash per share is 0.0112390168. Current and quick ratios are low and return-on-capital metrics are mixed. These fundamentals underline why dramatic intraday moves should be treated as volatility events rather than indicators of improved company earnings or cash flow.

Technicals and trading context for CHM.CN stock

Short-term technicals show the price above the 50-day average (C$0.042) and roughly in line with the 200-day average (C$0.048). Average volume is 28,908.00; absent a reported real-time volume spike, traders should verify trade prints and order book depth on CNQ.

For momentum traders, tight stop placement is essential: implied volatility here is high and the one-day move to C$0.05 can reverse quickly. Use limit orders and confirm settlement liquidity given the low nominal share price.

Sector context and risks: Healthcare environment for CHM.CN stock

Waverunner Capital sits in the Healthcare sector, Drug Manufacturers – Specialty & Generic industry. The Canadian healthcare sector shows average PE around 20.20 and mixed one-year performance. CHM.CN’s venture-capital investment profile and holdings in renewable energy and plant-based wellness differ from typical pharma operations, increasing comparability risks.

Sector risks include funding cycles for small-cap healthcare names and limited operating history. That heightens the probability that current price action is speculative rather than driven by sector fundamentals.

Meyka AI grade and model outlook for CHM.CN stock

Meyka AI rates CHM.CN with a score out of 100: 64.82 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a 12‑month reference price of C$0.08, compared with the current C$0.05, implying an upside of 60.00%. Forecasts are model-based projections and not guarantees. Investors should weigh this projection against negative earnings (EPS -0.01) and thin operating liquidity.

Trading strategy and risk management for CHM.CN stock

For short-term traders, treat CHM.CN as a high-volatility play: size positions small, set tight stops, and confirm execution on CNQ. The price action to C$0.05 is consistent with momentum or headline-driven flows rather than fundamental shifts.

For longer-term investors, the negative book value and weak liquidity metrics suggest a cautious stance. Use the Meyka grade (B, HOLD) and the C$0.08 model target as one input among many, and confirm company updates or filings before committing additional capital.

Final Thoughts

CHM.CN stock’s move to C$0.05 on 16 Feb 2026 and the reported 900.00% change highlight how low‑priced, small‑cap names can produce sharp intraday moves. Our review shows weak fundamental cushions — negative EPS (-0.01), negative book value per share, and limited cash per share (C$0.011). Sector context in Healthcare and the firm’s venture-style portfolio raise comparability and execution risk. Meyka AI rates CHM.CN with a score out of 100: 64.82 (Grade B, HOLD) and flags the stock as suitable for traders focused on short-term momentum rather than steady fundamental recovery. Meyka AI’s forecast model projects a 12‑month reference price of C$0.08, implying a 60.00% upside from C$0.05; forecasts are model-based projections and not guarantees. Key takeaway: expect high volatility, validate volume and trade prints on CNQ, and keep position sizes small when engaging with CHM.CN stock.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.